Global Lab-on-a-Chip and Microarrays (Biochip) Market to reach USD 33.3 billion by 2027.Global Lab-on-a-Chip and Microarrays (Biochip) Market is valued approximately at USD 13.36 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 13.96% over the forecast period 2021-2027. A lab-on-chip is a micro device that combines several laboratory analysis procedures onto a single chip. Using lab-on-chip technology, many laboratory analysis techniques such as biochemical detection, DNA sequencing, PCR, and others may be smoothly integrated. Parallelization, high assay sensitivity, ergonomy, waste minimization, and other benefits are all connected with this technique. The chip utilized in this technique can be as tiny as a few square centimeters and can handle very small fluid quantities, as low as picoliters. In the near future, the lab-on-chip market is expected to grow significantly. The rising demand for point-of-care testing, increasing incidences of chronic illnesses, and expanding use of proteomics and genomics in cancer research are the main drivers driving the overall market. For instance, according to the World Health Organization (WHO), chronic disease prevalence is expected to rise by 57 percent by 2020, with developing markets bearing 60 percent of the burden. Chronic diseases (CD) of various types are determined to be the leading causes of disability and morbidity across the world. Despite the fact that such diseases are chronic, accurate and fast clinical decision-making is important. However, availability of alternative technologies, may impede market growth over the forecast period of 2021-2027.

North America is found dominating the lab-on-a-chip and microarrays (biochip) market during the forecasted period Due to the presence of a high-quality healthcare system, the United States lab-on-a-chip and microarrays (biochip) market has a substantial market share in North America. With the escalating pandemic scenario, there is a significant need for COVID-19 rapid testing kits on the market, which is likely to complement the market's expansion in the United States. In resource-constrained situations, microfluidic technology is frequently used in the field of point-of-care (POC) diagnostics for diverse applications such as molecular diagnostics, infectious diseases, and chronic diseases.

Major market player included in this report are:
Danaher Corporation (Cepheid)
Abbott Laboratories
Thermo Fisher Scientific
F. Hoffmann-La Roche Ltd
Bio-Rad Laboratories Inc.
Agilent Technologies Inc.
Fluidigm Corporation
QIAGEN N.V.
PerkinElmer Inc.
GE Healthcare





The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Lab-on-a-chip
Microarray
By Products:
Instruments
Reagents and Consumables
Software and Services
By Application:
Clinical Diagnostics
Drug Discovery
Genomics and Proteomics
Other Applications
By End user:
Biotechnology & Pharmaceutical Companies
Hospitals & Diagnostics Centers
Academic & Research Institutes
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Lab-on-a-Chip and Microarrays (Biochip) Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors